| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pharmacology [D. C. L.] and Biochemistry [M. J. M., F. P. G.] and Center in Molecular Toxicology [D. C. L., M. J. M., F. P. G.], Vanderbilt University School of Medicine, Nashville, Tennessee 37232
Oxidation of the vinyl halide carcinogen and hepatotoxin vinylidene chloride (VDC) by microsomal cytochrome P-450 yields 2,2-dichloroacetaldehyde, 2-chloroacetyl chloride, 2-chloroacetic acid, and 1,1-dichloroethylene oxide. The roles of these metabolites in covalent modification of proteins and reduced glutathione (GSH) were examined. 2-Chloroacetyl chloride reacted with model thiols at least 103-fold faster than did 1,1-dichloroethylene oxide and at least 105-fold faster than did 2,2-dichloroacetaldehyde or 2-chloroacetic acid. Microsomal covalent binding of [14C]VDC was inhibited by GSH but not by lysine, suggesting that protein thiols, rather than amino groups, are major targets. Liver microsomes catalyzed the formation of three GSH:VDC metabolite conjugates, identified as S-(2,2-dichloro-1-hydroxy)ethylglutathione, 2-(S-glutathionyl)acetate, and S-(2-glutathionyl)acetylglutathione, a novel conjugate containing both stable (thioether) and labile (thioester) linkages. The latter two conjugates also were formed in isolated rat hepatocytes and measurable amounts of 2-(S-glutathionyl)acetate were released into the incubation medium. Both 2-(S-glutathionyl)acetate and S-(2-glutathionyl)acetylglutathione were formed with [35S]GSH added to the hepatic medium, indicating that reactive VDC metabolites are capable of crossing the plasma membrane to react with extracellular targets. Unlabeled S-(2-glutathionyl)-acetylglutathione underwent carbonyl substitution with added [35S]GSH, suggesting that this conjugate may participate in modification of protein thiols. This conjugate also underwent hydrolysis with a half-life of approximately 3 hr. GSH:VDC metabolite conjugates may serve as accessible models for labile covalent adducts formed between VDC metabolites and protein thiols.
1 This work was supported by USPHS Grants ES 02205 and ES 00267 and by Vanderbilt University Research Council Grant 361024.
2 Recipient of a Pharmaceutical Manufacturer's Association Foundation Advanced Predoctoral Fellowship. Present address: Department of Biochemistry and Biophysics, Oregon State University, Corvallis, OR 97331.
3 Burroughs Wellcome Scholar in Toxicology (1983 to 1988). To whom requests for reprints should be addressed, at Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232.
Received 5/21/84. Accepted 9/27/84.
This article has been cited by other articles:
![]() |
A. C. Simmonds, C. A. Reilly, R. M. Baldwin, B. I. Ghanayem, D. L. Lanza, G. S. Yost, K. S. Collins, and P.-G. Forkert BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES Drug Metab. Dispos., September 1, 2004; 32(9): 1032 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Martin, W. J. Racz, and P.-G. Forkert Mitochondrial Dysfunction Is an Early Manifestation of 1,1-Dichloroethylene-Induced Hepatotoxicity in Mice J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 121 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-G. Forkert and S. M. Boyd Differential Metabolism of 1,1-Dichloroethylene in Livers of A/J, CD-1, and C57BL/6 Mice Drug Metab. Dispos., November 1, 2001; 29(11): 1396 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-G. Forkert, S. M. Boyd, and J. B. Ulreich Pulmonary Bioactivation of 1,1-Dichloroethylene Is Associated with CYP2E1 Levels in A/J, CD-1, and C57BL/6 Mice J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1193 - 1200. [Abstract] [Full Text] |
||||
![]() |
P.-G. Forkert, P. D. Premdas, and R. J. Bowers Epoxide Formation from Diallyl Sulfone Is Associated with CYP2E1 Inactivation in Murine and Human Lungs Am. J. Respir. Cell Mol. Biol., November 1, 2000; 23(5): 687 - 695. [Abstract] [Full Text] |
||||
![]() |
F. P. Guengerich Metabolism of chemical carcinogens Carcinogenesis, March 1, 2000; 21(3): 345 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
P C Dartsch, H Wolburg, S A. Makdessi, D Schiek, H Sweidan, R Kimmel, and F W Schmahl Sodium monochloroacetate causes cytotoxic effects, an increased lactate and pyruvate level and induces ultra structural and cytoskeletal alterations in cultured kidney and liver epithelial cells Human and Experimental Toxicology, February 1, 2000; 19(2): 138 - 148. [Abstract] [PDF] |
||||
![]() |
P.-G. Forkert In Vivo Formation and Localization of 1,1-Dichloroethylene Epoxide in Murine Liver: Identification of Its Glutathione Conjugate 2-S-Glutathionyl Acetate J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1299 - 1306. [Abstract] [Full Text] |
||||
![]() |
P.-G. Forkert 1,1-Dichloroethylene-Induced Clara Cell Damage Is Associated with In Situ Formation of the Reactive Epoxide . Immunohistochemical Detection of Its Glutathione Conjugate Am. J. Respir. Cell Mol. Biol., June 1, 1999; 20(6): 1310 - 1318. [Abstract] [Full Text] |
||||
![]() |
T. F. Dowsley, K. Reid, D. Petsikas, J. B. Ulreich, R. L. Fisher, and P.-G. Forkert Cytochrome P-450-Dependent Bioactivation of 1,1-Dichloroethylene to a Reactive Epoxide in Human Lung and Liver Microsomes J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 641 - 648. [Abstract] [Full Text] |
||||
![]() |
T. E. Gram Chemically Reactive Intermediates and Pulmonary Xenobiotic Toxicity Pharmacol. Rev., December 1, 1997; 49(4): 297 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-G. Forkert, K. S. Collins, T. F. Dowsley, and G. M. Ross J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1422 - 1430. [Abstract] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |